Exposure-related health effects of silver and silver compounds: A review

Annals of Occupational Hygiene

Volumn 49, Issue 7, 2005, Pages 575-585

  Drake, Pamela L ^a   Hazelwood, Kyle J ^a,b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Argyria; Argyrosis; Occupational exposure; Occupational exposure limits; Silver

Indexed keywords

BLOOD; CELLS; DISCOLORATION; EXPOSURE CONTROLS; HEALTH CARE; IRRADIATION; MINING; RESPIRATORY MECHANICS; SILVER; SILVER COMPOUNDS; SKIN; TOXICITY;

ARGYRIA; ARGYROSIS; OCCUPATIONAL EXPOSURE; OCCUPATIONAL EXPOSURE LIMITS;

METAL ANALYSIS;

SILVER; SILVER DERIVATIVE;

ARGYRIA; BLOOD CELL; BLOOD TOXICITY; EYE COLOR; EYE IRRITATION; GASTROINTESTINAL TOXICITY; HEALTH HAZARD; HUMAN; INDUSTRIAL HYGIENE; LIVER TOXICITY; LONG TERM EXPOSURE; NEPHROTOXICITY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL HEALTH; OCCUPATIONAL SAFETY; OCCUPATIONAL TOXICOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SKIN DISCOLORATION; SKIN IRRITATION;

ARGYRIA; CHRONIC DISEASE; ENVIRONMENTAL EXPOSURE; EYE DISEASES; GUIDELINES; HUMANS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RESPIRATORY TRACT DISEASES; SILVER; SILVER COMPOUNDS; SOCIETIES, MEDICAL; SOLUBILITY; UNITED STATES;

EID: 26644473212     PISSN: 00034878     EISSN: 14753162     Source Type: Journal    
DOI: 10.1093/annhyg/mei019     Document Type: Review

References (94)

1. Aaseth J, Olsen A, Halse J et al. (1981) Argyria-tissue deposition of silver as selenide. Scan J Clin Lab Invest; 41: 247-51.
2. ACGIH. (1991) Documentation of the threshold limit values and biological exposure indices, 6th edn. Cincinnati, OH: American Conference of Governmental Industrial Hygienists.
3. ACGIH. (2001) Documentation of the threshold limit values and biological exposure indices. Supplement to 6th edn. Cincinnati, OH: American Conference of Governmental Industrial Hygienists.
4. Armitage SA, White MA, Wilson HK. (1996) The determination of silver in whole blood and its application to biological monitoring of occupationally exposed groups. Ann Occup Hyg; 40: 331-8.
5. ATSDR. (1990) Toxicological Profile for Silver. TP-90-24. Atlanta, GA: Agency for Toxic Substances and Disease Registry.
6. Baldi C, Minoia C, Di Nucci A et al. (1988) Effects of silver in isolated rat hepatocytes. Toxicol Lett; 41: 261-8.
7. Barrie HJ, Harding HE. (1947) Argyro-siderosis of the lungs in silver finishers. Br J Ind Med; 4: 225-32.
8. Berry JP, Galle P. (1982) Selenium and kidney deposits in experimental argyria. Pathol Biol; 30: 136-40.
9. Bouts BA. (1999) Argyria: images in clinical medicine. N Eng J Med; 340: 1554.
10. Breitstadt R. (1995) Occupational exposure limits for metallic silver. In Proceedings of the 2nd European Precious Metals Conference, Lisbon, Portugal. May 10-12, 1995; 1-13.
11. Brooks SM. (1981) Lung disorders resulting from the inhalation of metals. Clin Chest Med; 2: 235-54.
12. Buckley WR. (1963) Localized argyria. Arch Dermatol; 88: 531-9.
13. Buckley WR, Oster CF, Fasset DW. (1965) Localized argyria: II. Chemical nature of the silver containing particles. Arch Dematol; 92: 697-705.
14. Catsakis LH, Sulica VI. (1978) Allergy to silver amalgams. Oral Surg; 46: 371-5.
15. Danscher G. (1981) Light and electron microscopic localization of silver in biological tissue. Histochemistry; 71: 177-86.
16. DiVincenzo GD, Giordano CJ, Schriever LS. (1985) Biologic monitoring of workers exposed to silver. Int Arch Occup Environ Health; 56: 207-15.
17. East BW, Boddy K, Williams ED et al (1980) Silver retention, total body silver and tissue silver concentrations in argyria associated with exposure to an anti-smoking remedy containing silver acetate. Clin Exp Dermatol; 5: 305-11.
18. Egli KL. (2000) Argyria: consequences of using an antiquated medication. Dermatol Digest; 13: 103-07.
19. Espinal ML, Ferrando L, Jimenex DF. (1996) Asymptomatic blue nevus-like macule. Diagnosis: localized argyria. Arch Dermatol; 132: 461-4.
20. Etris SF. (2001) Silver and silver alloys. In Kirk-Othmer encyclopedia of chemical technology, 4th edn. New York: John Wiley & Sons, Inc.
21. Etris SF, Cappel CR. (2003) Silver compounds. In Kirk-Othmer encyclopedia of chemical technology, 4th edn. New York: John Wiley & Sons, Inc.
22. European Commission. (1994) Occupational exposure limits: recommendations of the scientific expert group 1991-92. EUR 15091. Luxembourg: European Commission.
23. Federal Register. (1999) Over-the-counter drug products containing colloidal silver ingredients or silver salts. 21 CFR Part 310, Rules and Regulations. FR Doc. 99-21253. Department of Health and Human Services, Food and Drug Administration; pp. 44653-8.
24. Fisher NM, Marsh E, Lazova R. (2003) Scar-localized argyria secondary to silver sulfadiazine cream. J Am Acad Dermatol; 49: 730-2.
25. Forycki Z, Zegarski W, Bardzik J et al. (1983) Acute silver poisoning through inhalation. Bull Inst Marit Trop Med Gdynia; 34: 199-203.
26. Fowler BA, Nordberg GF. (1986) Silver. In Friberg L, Nordberg GF, Vouk V, editors. Handbook on the toxicology of metals, 2nd edn, Vol II: Specific Metals. Amsterdam: Elsevier Science. pp. 521-31. ISBN 0 444 90442 5.
27. Fox CL, Rao TNV, Azmeth R et al. (1990) Comparative evaluation of zinc sulfadiazine and silver sulfadiazine in burn wound infection. J Burn Care Rehabil; 11: 112-17.
28. Fuller FW, Parrish M, Nance FC. (1994) A review of the dosimetry of 1% silver sulfadiazine cream in burn wound treatment. J Burn Care Rehabil; 15: 213.
29. Fung MC, Bowen DL. (1996) Silver products for medical indications: risk-benefit assessment. Clin Toxicol; 34: 119-26.
30. Furchner JE, Richmond CR, Drake GA. (1968) Comparative metabolism of radionuclides in mammals-IV. Retention of silver-110m in the mouse, rat, monkey and dog. Health Phys; 15: 505-14.
31. Furst A, Schlauder MC. (1978) Inactivity of two noble metals as carcinogens. J Environ Pathol Toxicol; 1: 51-7.
32. GFMS (2004) World silver survey 2004 - a summary. Washington DC: The Silver Institute; London, UK: Gold Fields Mineral Services. ISBN 1-880936-12-7.
33. Grabowski BF, Haney WG. (1972) Characterization of silver deposits in tissue resulting from dermal application of a silver-containing pharmaceutical. J Pharm Sci; 61: 1488-90.
34. Greene RM, Su WPD. (1987) Argyria. Am Fam Physician; 36: 151-4.
35. Gulbranson SH, Hud JA, Hansen RC. (2000) Argyria following the use of dietary supplements containing colloidal silver protein. Cutis; 66: 373-6.
36. Heyl T. (1979) Contact dermititis from silver coat. Contact Dermatitis; 5: 197.
37. Hill WR, Pillsbury DM. (1939) Argyria: the pharmacology of silver. Baltimore, MD: Williams & Wilkins Company.
38. Hollinger MA. (1996) Toxicological aspects of topical silver pharmaceuticals. Crit Rev Toxicol; 26: 255-60.
39. HSE. (1998) Metallic silver. HSE review 1996. Report no. D97. London, UK: Health and Safety Executive.
40. Hunter D. (1969) The diseases of occupations, 4th edn. Boston, MA: Little Brown and Co, p. 410.
41. Jacobs R. (1998) Rosemary's story. Accessed on November 2004. Available from http://homepages.together.net/~rjstan/ rose2.html.
42. James RC, Roberts SM, Williams PL. (2000) General principles of toxicology. In Williams PL, James RC, Roberts SM, editors. Principles of toxicology: environmental and industrial applications, 2nd edn. New York: John Wiley and Sons, Inc. pp. 3-4. ISBN 0-471-29321-0.
43. Jensen EJ, Rungby J, Hansen JC et al. (1988) Serum concentrations and accumulation of silver in skin during three months treatment with an anti-smoking chewing gum containing silver acetate. Hum Toxicol; 7: 535-40.
44. Jongerius O, Jongeneelen FJ. (1992) Occupational exposure limits. Criteria document for metallic silver. EUR 14314. Luxembourg: Commission of the European Communities. ISBN 92-826-4243-7.
45. Juberg DR, Hearne FT. (2001) Silver and gold. In Bingham E, Cohrssen B, Powell CH, editors. Patty's toxicology, 5th edn. New York: John Wiley & Sons (online version).
46. Klein DA, editor. (1978) Effects on humans. In Environmental impacts of artificial ice nucleating agents. Stroudburg, Dowden, Hutchinson, and Ross. pp. 169-75.
47. 3. J Dermatol; 21: 50-3.
48. Lewis RJ. (2001) Hawley's condensed chemical dictionary, 14th edn. New York: John Wiley & Sons. ISBN 0-471-38735-5.
49. Linnett P, Bradford CW. (1996) Cumulative exposure to metallic silver and absence of argyria: a survey at a silver recovery and recycling operation in UK. Unpublished study, London, UK: Johnson Matthey Research Centre.
50. Loeffler KU, Lee WR. (1987) Argyrosis of the lacrimal sac. Graefe's Arch Clin Exp Ophthalmol; 225: 146-50.
51. MacIntyre D. (1978) Silver poisoning associated with anti-smoking lozenge. Br Med J; 2: 1749-59.
52. Marks R. (1966) Contact dermatitis due to silver. Br J Dermatol; 78: 606-07.
53. Marshall JP II, Schneider RP. (1977) Systemic argyria secondary to topical silver nitrate. Arch Dermatol; 113: 1077-9.
54. Modak SM, Sampath L, Fox CL Jr. (1988) Combined topical use of silver sulfadiazine and antibiotics as a possible solution to bacterial resistance in burn wounds. J Burn Care Rehabil; 9: 359-63.
55. Moss AP, Sugar A, Hargett NA et al. (1979) The ocular manifestations and functional effects of occupational argyrosis. Arch Opthhalmol; 97: 906-08.
56. Newton D, Holmes A. (1966) A case of accidental inhalation of zinc-65 and silver-110m. Radiat Res; 29: 403-12.
57. NIOSH. (1992) Reports and Memoranda. NIOSH publication no. 92-100. U.S. Department of Health, Education, and Welfare.
58. NIOSH. (2003) Registry of toxic effects of chemical substances (RTECS): silver. VW3500000 (last updated August 2003) Cincinnati, OH: National Institute for Occupational Safety and Health. Available at http://www.cdc.gov/niosh/rtecs/ vw3567e0.html.
59. Nordberg G, Gerhardsson L. (1988) Silver. In Seiler HG, Sigel H, Sigel A, editors. Handbook on toxicity of inorganic compounds. New York: Marcel Dekker. pp. 619-24.
60. OSHA. (1989) United States Code of Federal Regulations, 29CFR Part 1910.1000, Air contaminants, final rule. Vol. 54. Washington, DC: Occupational Safety and Health Administration. p. 2702.
61. Payne CMER, Bladin C, Colchester ACF et al. (1992) Argyria from excessive use of topical silver sulphadiazine. Lancet; 340: 126.
62. Perrone S, Clonfero E, Gori G et al. (1977) Observations on four cases of occupational argyrosis. Med Lav; 68: 178-86.
63. Phalen RF, Morrow PE. (1973) Experimental inhalation of metallic silver. Health Phys; 24: 509-18.
64. Pifer JW, Friedlander BR, Kintz RT et al. (1989) Absence of toxic effects in silver reclamation workers. Scand J Work Environ Health; 15: 210-21.
65. Pruitt BA Jr, McManus AT, Kim SH et al. (1998) Burn wound infections: current status. World J Surg; 22: 135-45.
66. Rongioletti F, Robert E, Buffa P et al. (1992) Blue nevi-like dotted occupational argyria. J Am Acad Dermatol; 27: 1015-16.
67. Rosenblatt MJ, Cymet TC. (1987) Argyria: report of a case associated with abnormal electroencephalographic and brain scan findings. J Am Osteopath Assoc; 87: 509-12.
68. Rosenman KD, Moss A, Kon S. (1979) Argyria: clinical implications of exposure to silver nitrate and silver oxide. J Occup Med; 21: 430-5.
69. Rosenman KD, Seixas N, Jacobs I. (1987) Potential nephrotoxic effects of exposure to silver. Br J Ind Med; 44: 267-72.
70. Saint S, Veenstra DL, Sullivan SD et al. (2000) The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Arch Intern Med; 160: 2670-5.
71. Sánchez-Huerta V, DeWit-Carter G, Hernández-Quintela E et al. (2003) Occupational corneal argyrosis in art silver solderers. Cornea; 22: 604-11.
72. Sato S, Sueki H, Nishijima A. (1999) Two unusual cases of argyria: the application of an improved tissue processing method for X-ray microanalysis of selenium and sulphur in silver-laden granules. Br J Dermatol; 140: 158-63.
73. Scott KG, Hamilton JG. (1950) The metabolism of silver in the rat with radiosilver used as an indicator. Publ Pharmacol; 2: 241-62.
74. Scroggs MW, Lewis JS, Proia AD. (1992) Corneal argyrosis associated with silver soldering. Cornea; 11: 264-9.
75. Shall L, Stevens A, Millard LG. (1990) An unusual case of acquired localized argyria. Br J Dermatol; 123: 403-07.
76. Shelley WB, Shelley ED, Burmeister V. (1987) Argyria: the intradermal "photograph", a manifestation of passive photosensitivity. J Am Acad Dermatol; 16: 211-17.
77. Shelton D, Goulding R. (1979) Silver poisoning associated with an antismoking lozenge. Br Med J; 1: 267.
78. Silver S. (2003) Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev; 27: 341-53.
79. Smith IC, Carson BL. (1977) Trace metals in the environment, Vol. 2 - Silver. Ann Arbor, Michigan: Ann Arbor Science.
80. Steininger H, Langer E, Stommer P. (1990) Generalized argyria. Dtsch Med Wochenschr; 115: 657-62. (in German).
81. Sue YM, Lee JYY, Wang MC et al. (2001) Generalized argyria in two chronic hemodialysis patients. Am J Kidney Dis; 37: 1048-51.
82. Sugden P, Azad S, Erdmann M. (2001) Argyria caused by an earring. Br J Plast Surg; 54: 252-3.
83. Tanita Y, Kato T, Hanada K et al. (1985) Blue macules of localized argyria caused by implanted acupuncture needles. Arch Dermatol; 121: 1550-2.
84. Tomi NS, Kränke B, Aberer W. (2004) A silver man. Lancet; 363: 532.
85. Van den Nieuwenhuijsen IJ, Calame JJ, Bruynzeel DP. (1988) Localized argyria caused by silver earrings. Dermatologica; 177: 189-91.
86. Van Garsse L, Versieck J. (1995) Generalized argyria caused by administration of tobacco-withdrawal tablets containing silver acetate. Ned Tijdschr Geneeskd; 139: 2658-61. (in Dutch).
87. Venugopal B, Luckey TD, editors. (1978) Metal toxicity in mammals. In Chemical toxicology of metals and metalloids. New York: Acedemic Press. pp. 32-36.
88. Wan AT, Conyers RA, Coombs CJ, Masterton JP. (1991) Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clin Chem; 37: 1683-7.
89. Watanabe K. (1989) Histopathological study of damage to periodontal tissues by silver alloy metals in rats. J Jpn Assoc Periodontal; 31: 1021-46. (in Japanese).
90. Weir FW. (1979) Health hazard from occupational exposure to metallic copper and silver dust. Am Ind Hyg Assoc J; 40: 245-7.
91. White JML, Powell AM, Brady K et al. (2003) Severe generalized argyria secondary to ingestion of colloidal silver protein. Clin Dermatol; 28: 254-6.
92. Williams N. (1999) Longitudinal medical surveillance showing lack of progression of argyrosis in a silver refiner. Occup Med; 49: 397-9.
93. Williams N, Gardner I. (1995) Absence of symptoms in silver refiners with raised blood silver levels. Occup Med; 45: 205-08.
94. Wobling RH, Milradt R, Schopenhauer-Germann E et al. (1988) Argyrosis in employees of the silver processing industry. Arbeitsmed Sozialmed Praventivmed; 23: 293-7.